Know Cancer

or
forgot password

Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT


N/A
40 Years
80 Years
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT


Inclusion Criteria:



- Age 40 to 80 years old

- Language spoken: Finnish or Swedish

- Performance status: Karnofsky score 70 or better or WHO performance status 2 or
better

- earlier diagnosed (histologically confirmed) colorectal cancer with discovered
metastases at operation

- Earlier diagnosed and treated colorectal cancer with discovered recurrence in the
follow up

- Mental status: Patients must be able to understand the meaning of the study

- Informed consent: The patient must sign the appropriate Ethical Committee (EC)
approved informed consent documents in the presence of the designated staff

Exclusion Criteria:

- Prior medical history: Patient must have no history of serious cardiovascular, liver
or kidney disease

- Vulnerable study subjects such as described in Finnish law concerning clinical
studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be
included.

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Survival

Outcome Time Frame:

2 years

Safety Issue:

No

Authority:

Finland: Finnish Medicines Agency

Study ID:

RESCORE

NCT ID:

NCT00823810

Start Date:

December 2008

Completion Date:

December 2014

Related Keywords:

  • Colorectal Cancer
  • Colorectal cancer
  • Response to treatment
  • FDG PET/CT
  • Colorectal Neoplasms

Name

Location